Social Media Content Creators Fueling Unofficial Trade for Unlicensed Slimming Drug
An underground market for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.
Investigational Drug Gaining Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are encouraged to message these accounts directly for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before directing customers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Experts Voice Concerns
Nevertheless, physicians and chemists have warned that the sale of what is still an unapproved drug in the UK is worrisome and could result in individuals injecting products of uncertain source.
Some experts stated the demand for retatrutide could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Several content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and distribution can still breach pharmaceutical, advertising, and customer laws, risking fines, prosecution or prison.
Service Response and Material Removal
According to the social media company, the service has taken down problematic material and banned related hashtags and search suggestions. The company said it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.
Online Trading Activities
Investigations also found groups with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with photos of weight loss, glowing testimonials and step-by-step guides for mixing or administering at home.
After minutes of entering one community, a seller shared WhatsApp details, where most purchases occur. The seller provided an guidebook and guaranteed delivery within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or past usage.
Item Information and Costs
Inside these groups, messages show dark colored parcels with Royal Mail labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at residence with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20mg. When questioned how long a pen should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for the messaging service said it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are injecting substances they can’t verify. Even if the research behind retatrutide is sound, these online products may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she explained.
Her staff has already encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company investigational product not yet authorized … may expose users to possibly serious medical dangers”.
